CORC

在结果中检索

CORC

浏览/检索结果: 共19条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Human substance P receptor binding mode of the antagonist drug aprepitant by NMR and crystallography 期刊论文
NATURE COMMUNICATIONS, 2019, 卷号: 10, 页码: 8
作者:  Chen, Shuanghong;  Lu, Mengjie;  Liu, Dongsheng;  Yang, Lingyun;  Yi, Cuiying
收藏  |  浏览/下载：14/0  |  提交时间：2020/07/01
The Effects of Neurokinin-1 Receptor Antagonist in an Experimental Autoimmune Cystitis Model Resembling Bladder Pain Syndrome/Interstitial Cystitis 期刊论文
INFLAMMATION, 2019, 卷号: 42, 期号: 1
作者:  Liu, Bo-Ke;  Jin, Xing-Wei;  Lu, Hao-Zhong;  Zhang, Xiang;  Zhao, Zhong-Hua
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
Human substance P receptor binding mode of the antagonist drug aprepitant by NMR and crystallography 期刊论文
NATURE COMMUNICATIONS, 2019, 卷号: 10
作者:  Chen, Shuanghong;  Lu, Mengjie;  Liu, Dongsheng;  Yang, Lingyun;  Yi, Cuiying
收藏  |  浏览/下载：27/0  |  提交时间：2019/12/05
Efficacy, Tolerability and Pharmacokinetic Impact of Aprepitant in Sarcoma Patients Receiving Ifosfamide and Doxorubicin Chemotherapy: A Randomized Controlled Trial 期刊论文
ADVANCES IN THERAPY, 2019, 卷号: Vol.36 No.2, 页码: 355-364
作者:  Xiong, Jie;  Zhao, Guifang;  Yang, Shengli;  Chen, Jing
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/13
MiR‐34b/c‐5p and the neurokinin‐1 receptor regulate breast cancer cell proliferation and apoptosis 期刊论文
Cell Proliferation, 2019, 卷号: Vol.52 No.1
作者:  Lufang Zhang;  Lushan Wang;  Dong Dong;  Zhiyong Wang;  Wei Ji
收藏  |  浏览/下载：16/0  |  提交时间：2019/12/17
MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis 期刊论文
CELL PROLIFERATION, 2019, 卷号: Vol.52 No.1
作者:  Zhang, Lufang;  Wang, Lushan;  Dong, Dong;  Wang, Zhiyong;  Ji, Wei
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/17
Efficacy, Tolerability and Pharmacokinetic Impact of Aprepitant in Sarcoma Patients Receiving Ifosfamide and Doxorubicin Chemotherapy: A Randomized Controlled Trial 期刊论文
Advances in Therapy, 2019, 卷号: Vol.36 No.2, 页码: 355-364
作者:  Jie Xiong;  Guifang Zhao;  Shengli Yang;  Jing Chen
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/13
Efficacy, Tolerability and Pharmacokinetic Impact of Aprepitant in Sarcoma Patients Receiving Ifosfamide and Doxorubicin Chemotherapy: A Randomized Controlled Trial. 期刊论文
Advances in therapy, 2019
作者:  Xiong Jie;  Zhao Guifang;  Yang Shengli;  Chen Jing
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/13
A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC) 期刊论文
ANNALS OF ONCOLOGY, 2018, 卷号: 29, 期号: 2
作者:  Zhang, L.;  Lu, S.;  Feng, J.;  Dechaphunkul, A.;  Chang, J.
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Phase III Randomized Trial of Palonosetron and Dexamethasone With or Without Aprepitant to Prevent Nausea and Vomiting Induced by Full-dose Single-day Cisplatin-based Chemotherapy in Lung Cancer 期刊论文
Clinical lung cancer, 2018, 卷号: 19, 期号: 6, 页码: e913-e918
作者:  Wu, Fang;  Lin, Xiaoping;  Yang, Zhanghuan;  Sun, Ziyi;  Zeng, Fanxu
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/27

©版权所有 ©2017 CSpace - Powered by CSpace